Stoke Therapeutics, Inc. · NASDAQ:STOK
Kaye Edward M. MD sold 12,567 Stoke Therapeutics, Inc. shares (Form 4)
Traded Aug 14 to Aug 18, 2026 · Filed Aug 18, 2026
From Aug 14 to Aug 18, 2026, Kaye Edward M. MD (Director) sold 12,567 Stoke Therapeutics, Inc. shares at an average US$32.03 for US$403K, leaving 124,557 shares. Filed Aug 18, 2026 (Form 4).
- Sold
- 12,567 shares
- Price
- US$32.03 average (US$32.01 to US$32.47)
- Value
- US$403K
- Holding after
- 124,557 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Common Stock | Option exercise | 26,250 | 137,124 | Direct | |
| Aug 18, 2026 | Common Stock | Sale | 11,930 | US$32.01 | 125,194 | Direct |
| Aug 18, 2026 | Common Stock | Sale | 637 | US$32.47 | 124,557 | Direct |